Long-term Safety & Tolerability of BHV-7000

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02245061` - Cortical Excitability Assessment Using Paired Pulses	N/A
Terminated	`NCT05081518` - A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy	Phase 1
Withdrawn	`NCT05481905` - ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures	Phase 2
Completed	`NCT02208492` - The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study	Phase 4
Recruiting	`NCT04839601` - RNS System RESPONSE Study	N/A
Completed	`NCT02898935` - Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy
Enrolling by invitation	`NCT05748236` - The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy	Phase 4
Terminated	`NCT01724918` - Lacosamide IV and EEG/EKG (LIVE) Study	Phase 2
Completed	`NCT00855738` - A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice	Phase 4
Recruiting	`NCT06309966` - Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy	Phase 2/Phase 3
Not yet recruiting	`NCT06210022` - Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy
Completed	`NCT01311440` - Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy	N/A
Terminated	`NCT03955432` - Long-term Cardiac Monitoring in Epilepsy	N/A
Recruiting	`NCT06132893` - A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy	Phase 2/Phase 3
Recruiting	`NCT05100771` - Optimized Volumetry in Radiology: Interest in Pediatric Brain MRI in the Exploration of Focal Epilepsy
Recruiting	`NCT04879433` - Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
Active, not recruiting	`NCT03916848` - Novel Network Analysis of Intracranial Stereoelectroencephalography	N/A
Recruiting	`NCT05198882` - Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy	Phase 1
Recruiting	`NCT05981755` - Breathing Rescue for SUDEP Prevention	N/A
Recruiting	`NCT03457961` - Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong

NCT number	NCT06443463
Study type	Interventional
Source	Biohaven Pharmaceuticals, Inc.
Contact	Chief Medical Officer
Phone	203-404-0410
Email	clinicaltrials@biohavenpharma.com
Status	Not yet recruiting
Phase	Phase 2
Start date	July 2024
Completion date	January 2027

Long-term Safety and Tolerability of BHV-7000

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms